Beyond Pooled – Part of the BEYOND study program (Benefit of NOACs study of non-valvular AF patients in nordic countries) (BEYOND Pooled (Denmark, Norway, Sweden))

Study identification

• EU PAS number:
  EUPAS13470
• Study ID:
  33157
• Official title and acronym:
  Beyond Pooled – Part of the BEYOND study program (Benefit of NOACs study of non-valvular AF patients in nordic countries) (BEYOND Pooled (Denmark, Norway, Sweden))
• DARWIN EU® study:
  No
• Study countries:
  Denmark

  Norway

  Sweden
• Study description:
  The overall aim of this study is to evaluate effectiveness and safety of each NOAC compared with warfarin in treatment-naïve initiators of anticoagulants with NVAF in routine clinical practice in Denmark, Norway and Sweden. The study will use pooled data from nationwide registries in Denmark, Norway and Sweden.
• Study status:
  Finalised

Research institutions and networks

Institutions

Aarhus University & Aarhus University Hospital DEPARTMENT OF CLINICAL EPIDEMIOLOGY

Denmark

Centre for Pharmacoepidemiology, Karolinska Institutet (CPE-KI)

Sweden

Department of Clinical Epidemiology Olof Palmes Allé 43-45, Department of Global Public Health and Primary Care Kalfarveien 31, NO-5018 Bergen, Norway

Study timelines

Date when funding contract was signed

Actual: 15/12/2015

Study start date

Planned: 01/10/2017

Actual: 17/08/2018

Data analysis start date

Planned: 22/11/2018

Actual: 30/11/2018

Date of final study report

Planned: 31/08/2019

Actual: 29/07/2019

Sources of funding

Pharmaceutical company and other private sector 

More details on funding

Pfizer, Inc.

Regulatory

• Was the study required by a regulatory body?:
  No
• Is the study required by a Risk Management Plan (RMP)?:
  Not applicable

Other study registration identification numbers and links

CCTR protocol number: B0661103